Andhra Petrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:28 pm

Quick Insight

Andhra Petrochemicals Ltd's current share price of ₹52.2, with a market cap of ₹444 Cr., reflects a challenging scenario as indicated by a negative P/E ratio. The company's low ROE and ROCE of 2.75% and 1.57% respectively suggest inefficiencies in capital utilization. Furthermore, the negative operating profit margin of -11% and net profit of -18 indicate operational struggles. With a high level of borrowings at ₹86 Cr. and a low ICR of 0.53x, Andhra Petrochemicals faces financial risk. The substantial promoter holding of 45.04% provides some stability, but the lack of institutional investor interest is concerning. In conclusion, Andhra Petrochemicals Ltd. appears to be in a precarious financial position with significant challenges to overcome for sustainable growth.

Competitors of Andhra Petrochemicals Ltd

All Competitor Stocks of Andhra Petrochemicals Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:01 am

Below is a detailed analysis of the quarterly data for Andhra Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 143.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Dec 2024) to 143.00 Cr., marking an increase of 18.00 Cr..
• For Expenses, as of Mar 2025, the value is 160.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 145.00 Cr. (Dec 2024) to 160.00 Cr., marking an increase of 15.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -16.00 Cr.. The value appears strong and on an upward trend. It has increased from -21.00 Cr. (Dec 2024) to -16.00 Cr., marking an increase of 5.00 Cr..
• For OPM %, as of Mar 2025, the value is -11.00%. The value appears strong and on an upward trend. It has increased from -17.00% (Dec 2024) to -11.00%, marking an increase of 6.00%.
• For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 4.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -19.00 Cr.. The value appears strong and on an upward trend. It has increased from -20.00 Cr. (Dec 2024) to -19.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Mar 2025, the value is -21.00%. The value appears to be increasing, which may not be favorable. It has increased from -22.00% (Dec 2024) to -21.00%, marking an increase of 1.00%.
• For Net Profit, as of Mar 2025, the value is -15.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded -15.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.79. The value appears to be declining and may need further review. It has decreased from -1.78 (Dec 2024) to -1.79, marking a decrease of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:00 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:53 pm

Below is a detailed analysis of the balance sheet data for Andhra Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 85.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 85.00 Cr..
• For Reserves, as of Mar 2025, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 471.00 Cr. (Mar 2024) to 436.00 Cr., marking a decrease of 35.00 Cr..
• For Borrowings, as of Mar 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 84.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 47.00 Cr.. The value appears to be improving (decreasing). It has decreased from 57.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 10.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 653.00 Cr.. The value appears to be improving (decreasing). It has decreased from 696.00 Cr. (Mar 2024) to 653.00 Cr., marking a decrease of 43.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 209.00 Cr. (Mar 2024) to 196.00 Cr., marking a decrease of 13.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 386.00 Cr.. The value appears to be declining and may need further review. It has decreased from 422.00 Cr. (Mar 2024) to 386.00 Cr., marking a decrease of 36.00 Cr..
• For Total Assets, as of Mar 2025, the value is 653.00 Cr.. The value appears to be declining and may need further review. It has decreased from 696.00 Cr. (Mar 2024) to 653.00 Cr., marking a decrease of 43.00 Cr..

Notably, the Reserves (436.00 Cr.) exceed the Borrowings (86.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Andhra Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -2.13. This value is below the healthy minimum of 5. It has decreased from 7.46 (Mar 24) to -2.13, marking a decrease of 9.59.
• For Diluted EPS (Rs.), as of Mar 25, the value is -2.13. This value is below the healthy minimum of 5. It has decreased from 7.46 (Mar 24) to -2.13, marking a decrease of 9.59.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 3. It has decreased from 9.21 (Mar 24) to -0.41, marking a decrease of 9.62.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.28. It has decreased from 65.40 (Mar 24) to 61.28, marking a decrease of 4.12.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.28. It has decreased from 65.40 (Mar 24) to 61.28, marking a decrease of 4.12.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 2.00 (Mar 24) to 0.00, marking a decrease of 2.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 59.06. It has decreased from 92.82 (Mar 24) to 59.06, marking a decrease of 33.76.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 2. It has decreased from 12.90 (Mar 24) to 0.56, marking a decrease of 12.34.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.15. This value is below the healthy minimum of 0. It has decreased from 11.15 (Mar 24) to -1.15, marking a decrease of 12.30.
• For PBT / Share (Rs.), as of Mar 25, the value is -2.60. This value is below the healthy minimum of 0. It has decreased from 10.13 (Mar 24) to -2.60, marking a decrease of 12.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -2.13. This value is below the healthy minimum of 2. It has decreased from 7.46 (Mar 24) to -2.13, marking a decrease of 9.59.
• For PBDIT Margin (%), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 10. It has decreased from 13.89 (Mar 24) to 0.96, marking a decrease of 12.93.
• For PBIT Margin (%), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 10. It has decreased from 12.01 (Mar 24) to -1.94, marking a decrease of 13.95.
• For PBT Margin (%), as of Mar 25, the value is -4.40. This value is below the healthy minimum of 10. It has decreased from 10.91 (Mar 24) to -4.40, marking a decrease of 15.31.
• For Net Profit Margin (%), as of Mar 25, the value is -3.61. This value is below the healthy minimum of 5. It has decreased from 8.03 (Mar 24) to -3.61, marking a decrease of 11.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is -3.48. This value is below the healthy minimum of 15. It has decreased from 11.41 (Mar 24) to -3.48, marking a decrease of 14.89.
• For Return on Capital Employeed (%), as of Mar 25, the value is -1.58. This value is below the healthy minimum of 10. It has decreased from 14.49 (Mar 24) to -1.58, marking a decrease of 16.07.
• For Return On Assets (%), as of Mar 25, the value is -2.77. This value is below the healthy minimum of 5. It has decreased from 9.10 (Mar 24) to -2.77, marking a decrease of 11.87.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has decreased from 1.18 (Mar 24) to 0.74, marking a decrease of 0.44.
• For Current Ratio (X), as of Mar 25, the value is 11.80. This value exceeds the healthy maximum of 3. It has increased from 10.44 (Mar 24) to 11.80, marking an increase of 1.36.
• For Quick Ratio (X), as of Mar 25, the value is 10.36. This value exceeds the healthy maximum of 2. It has increased from 9.53 (Mar 24) to 10.36, marking an increase of 0.83.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.53. This value exceeds the healthy maximum of 8. It has decreased from 10.70 (Mar 24) to 9.53, marking a decrease of 1.17.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.10 (Mar 24) to 0.00, marking a decrease of 20.10.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.29 (Mar 24) to 0.00, marking a decrease of 16.29.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.90 (Mar 24) to 0.00, marking a decrease of 79.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.71 (Mar 24) to 0.00, marking a decrease of 83.71.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 3. It has decreased from 12.65 (Mar 24) to 0.53, marking a decrease of 12.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.63. This value is below the healthy minimum of 3. It has decreased from 8.32 (Mar 24) to -0.63, marking a decrease of 8.95.
• For Enterprise Value (Cr.), as of Mar 25, the value is 126.33. It has decreased from 406.35 (Mar 24) to 126.33, marking a decrease of 280.02.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. It has decreased from 0.51 (Mar 24) to 0.25, marking a decrease of 0.26.
• For EV / EBITDA (X), as of Mar 25, the value is 26.19. This value exceeds the healthy maximum of 15. It has increased from 3.71 (Mar 24) to 26.19, marking an increase of 22.48.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.82, marking a decrease of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 79.89 (Mar 24) to 0.00, marking a decrease of 79.89.
• For Price / BV (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.30 (Mar 24) to 0.79, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.82, marking a decrease of 0.09.
• For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to -0.04, marking a decrease of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness